Emergent iclusig pharm order
Ended Awarded
- Contract number
- 36C26024F0120
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $26,087
Award facts
- Contract value 100% obligated
- $26,086.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Cambridge, MA 02139, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration awarded a $26,086.86 delivery order against Takeda Pharmaceuticals America, Inc.'s Pharmaceuticals and Drugs Federal Supply Schedule contract. Takeda will provide EMERGENT ICLUSIG PHARM ORDER to Veterans Integrated Service Network 20 in Cambridge, Massachusetts over a period of performance from December 12, 2023 through February 29, 2024 under firm fixed pricing terms. As the prime contractor, Takeda Pharmaceuticals America is a subsidiary of Takeda Pharmaceutical Company LIMITED and will utilize its GSA Schedule 61-IB vehicle to fulfill this order for pharmaceutical products to support the VA's healthcare services for veterans in the New England region.
Quick answers
Who was awarded contract 36C26024F0120?
36C26024F0120 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on December 12, 2023.
How much is contract 36C26024F0120 worth?
The government has obligated $26,087 on 36C26024F0120.
Is contract 36C26024F0120 an order under another contract?
Yes. 36C26024F0120 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26024F0120 competed?
The extent of competition for 36C26024F0120 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award